Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cell Chemical Biology
|
June 8, 2026
Chemical modulation of Miro1 alleviates cell-type-specific vulnerabilities in Friedreich's ataxia
Sujyoti Chandra, Chulhwan S Kwak, Zehui Du, et al.
Frontiers in Pharmacology
|
December 20, 2021
Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer's Disease Brain Tissue Reveals Disease-Associated Signatures
Whitaker Cohn, Mikhail Melnik, Calvin Huang, et al.
Molecular Brain
|
April 20, 2021
Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
Molecular Brain
|
July 9, 2021
Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
The Journal of Clinical Investigation
|
July 11, 2018
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology
Suresh B Rangasamy, Malabendu Jana, Avik Roy, et al.
ACS Chemical Biology
|
May 1, 2020
Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
Tina Bilousova, Bryan J Simmons, Rachel R Knapp, et al.
Cell Reports
|
December 7, 2023
A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's disease
Vinita Bharat, Aarooran S Durairaj, Roeland Vanhauwaert, et al.
Scientific Reports
|
April 24, 2025
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease
Jesus Campagna, Sujyoti Chandra, Bruce Teter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Samar Padder, Jesus J Campagna, Sujyoti Chandra, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cell Chemical Biology
|
June 8, 2026
Chemical modulation of Miro1 alleviates cell-type-specific vulnerabilities in Friedreich's ataxia
Sujyoti Chandra, Chulhwan S Kwak, Zehui Du, et al.
Frontiers in Pharmacology
|
December 20, 2021
Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer's Disease Brain Tissue Reveals Disease-Associated Signatures
Whitaker Cohn, Mikhail Melnik, Calvin Huang, et al.
Molecular Brain
|
April 20, 2021
Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
Molecular Brain
|
July 9, 2021
Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
The Journal of Clinical Investigation
|
July 11, 2018
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology
Suresh B Rangasamy, Malabendu Jana, Avik Roy, et al.
ACS Chemical Biology
|
May 1, 2020
Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
Tina Bilousova, Bryan J Simmons, Rachel R Knapp, et al.
Cell Reports
|
December 7, 2023
A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's disease
Vinita Bharat, Aarooran S Durairaj, Roeland Vanhauwaert, et al.
Scientific Reports
|
April 24, 2025
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease
Jesus Campagna, Sujyoti Chandra, Bruce Teter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Samar Padder, Jesus J Campagna, Sujyoti Chandra, et al.
Page
of 2